CONSOLIDATED STATEMENTS OF (DEFICIT) EQUITY - USD ($) $ in Thousands	Series A Convertible Preferred Stock Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance Beginning at Dec. 31, 2022	$ 4,043	$ 50	$ 542,428			$ (430,521)	$ 116,000
Balance Beginning (in shares) at Dec. 31, 2022	4,300	49,642,767		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			3,741				3,741
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		22,350
Unrealized gain (loss) on short-term investments					$ 74		74
Net income (loss)						(34,730)	(34,730)
Balance Ending at Mar. 31, 2023	$ 4,043	$ 50	546,169		74	(465,251)	85,085
Balance Ending (in shares) at Mar. 31, 2023	4,300	49,665,117		7,307
Balance Beginning at Dec. 31, 2022	$ 4,043	$ 50	542,428			(430,521)	$ 116,000
Balance Beginning (in shares) at Dec. 31, 2022	4,300	49,642,767		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock in connection with at-the-market facility offering (average price of $7.17 per share), net of expenses of $529 (in shares)							0
Balance Ending at Sep. 30, 2023		$ 55	584,710		(71)	(530,157)	$ 54,537
Balance Ending (in shares) at Sep. 30, 2023		54,573,490		7,307
Balance Beginning at Mar. 31, 2023	$ 4,043	$ 50	546,169		74	(465,251)	85,085
Balance Beginning (in shares) at Mar. 31, 2023	4,300	49,665,117		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			3,891				3,891
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		11,625
Exercise of stock options			485				485
Exercise of stock options (in shares)		72,440
Conversion of convertible preferred stock into common	$ (4,043)	$ 1	4,042
Conversion of convertible preferred stock into common stock (in shares)	(4,300)	860,000
Unrealized gain (loss) on short-term investments					(188)		(188)
Net income (loss)						(31,934)	(31,934)
Balance Ending at Jun. 30, 2023		$ 51	554,587		(114)	(497,185)	57,339
Balance Ending (in shares) at Jun. 30, 2023		50,609,182		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			4,006				4,006
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		224,170
Exercise of stock options			298				298
Exercise of stock options (in shares)		50,338
Issuance of common stock in connection with at-the-market facility offering (average price of $7.17 per share), net of expenses of $529		$ 4	25,819				$ 25,823
Issuance of common stock in connection with at-the-market facility offering (average price of $7.17 per share), net of expenses of $529 (in shares)		3,689,800					0
Unrealized gain (loss) on short-term investments					43		$ 43
Net income (loss)						(32,972)	(32,972)
Balance Ending at Sep. 30, 2023		$ 55	584,710		(71)	(530,157)	54,537
Balance Ending (in shares) at Sep. 30, 2023		54,573,490		7,307
Balance Beginning at Dec. 31, 2023		$ 55	588,656		(20)	(571,926)	16,765
Balance Beginning (in shares) at Dec. 31, 2023		54,578,121		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			5,193				5,193
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		295,256
Exercise of stock options			257				257
Exercise of stock options (in shares)		57,665
Unrealized gain (loss) on short-term investments					20		20
Net income (loss)						(38,669)	(38,669)
Balance Ending at Mar. 31, 2024		$ 55	594,106			(610,595)	(16,434)
Balance Ending (in shares) at Mar. 31, 2024		54,931,042		7,307
Balance Beginning at Dec. 31, 2023		$ 55	588,656		$ (20)	(571,926)	$ 16,765
Balance Beginning (in shares) at Dec. 31, 2023		54,578,121		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock in connection with at-the-market facility offering (average price of $7.17 per share), net of expenses of $529 (in shares)							0
Net income (loss)							$ (98,700)
Balance Ending at Sep. 30, 2024		$ 55	603,853			(670,648)	(66,740)
Balance Ending (in shares) at Sep. 30, 2024		55,185,622		7,307
Balance Beginning at Mar. 31, 2024		$ 55	594,106			(610,595)	(16,434)
Balance Beginning (in shares) at Mar. 31, 2024		54,931,042		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			4,917				4,917
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		32,877
Net income (loss)						(35,828)	(35,828)
Balance Ending at Jun. 30, 2024		$ 55	599,023			(646,423)	(47,345)
Balance Ending (in shares) at Jun. 30, 2024		54,963,919		7,307
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense			4,830				$ 4,830
Net issuance of common stock in connection with the vesting of restricted stock (in shares)		221,703
Issuance of common stock in connection with at-the-market facility offering (average price of $7.17 per share), net of expenses of $529 (in shares)							0
Net income (loss)						(24,225)	$ (24,225)
Balance Ending at Sep. 30, 2024		$ 55	$ 603,853			$ (670,648)	$ (66,740)
Balance Ending (in shares) at Sep. 30, 2024		55,185,622		7,307